L'Utile Operativo Cambiamento Data
AstraZeneca USD 3.16B 3.95B 2026-06
Genmab DKK 407M 182M 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
GRIFOLS EUR 329M 80M 2026-06
Hikma Pharmaceutical USD 348M 161M 2025-12
Lakefront Biotherapeutics EUR -43.51M 20.19M 2026-06
Qiagen NV USD 141.4M 24.77M 2026-06
UCB EUR 1.29B 571M 2025-12